Publications by authors named "Merran Macpherson"

Claim this Profile
S
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector.
Michael Sebastian, Jerry Bagel, Bengt Hoepken, Bertram Knapp, Ceyhun Bicer, Merran MacPherson

Dermatol Ther (Heidelb)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil.
Hugues Chanteux, Merran MacPherson, Hester Kramer, Christian Otoul, Takuya Okagaki

Expert Opin Drug Metab Toxicol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.
Shampa Das, Todd Riccobene, Timothy J Carrothers, James G Wright, Merran MacPherson

Eur J Clin Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development.
Hester Kramer, Ceyhun Bicer, Christian Otoul, Chiara Rospo, Merran Macpherson

AAPS J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials.
Michael Rademacher, Manuel Toledo, Wim Van Paesschen, Kore K Liow, Ivan G Milanov, Merran MacPherson

Epilepsia Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.
Andrew Cristinacce, James G Wright, Merran Macpherson, Joseph Iaconis, Shampa Das

Diagn Microbiol Infect Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.
Jianguo Li, Mark Lovern, Michelle L Green, Joannellyn Chiu, Diansong Zhou, Merran MacPherson

Clin Transl Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.
Wright W Nichols, Gregory G Stone, Paul Newell, Helen Broadhurst, Angela Wardman, Merran MacPherson

Antimicrob Agents Chemother· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers.
Richard Dimelow, James G Wright, Merran MacPherson, Paul Newell, Shampa Das

Drugs R D· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia.
Merran Macpherson, Bengt Hamrén, Marjet J A M Braamskamp, John J P Kastelein, Torbjörn Lundström

Eur J Clin Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib.
Jiri Horak, Jeff White, Adrian L Harris, Mark Verrill, James Carmichael, Merran Macpherson

Cancer Chemother Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).
Kathleen I Pritchard, Janusz Rolski, Zsuzsanna Papai, Louis Mauriac, Fatima Cardoso, Merran P Macpherson

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
Elspeth Lamont, R Andrew Seaton, Merran Macpherson, Lindsay Semple, Emma Bell

J Antimicrob Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers.
Mireille V Cantarini, Merran P Macpherson, Anna L Marshall, Anna V Robinson, Christopher J Bailey

Cancer Chemother Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis